PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, Ohio.\', \'Heart, Vascular and Thoracic Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.\', \'Section of Cardiovascular Research, Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, Akron, Ohio.\', \'Lerner Research Institute, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.\', \'Pathology and Laboratory Medicine Institute, Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio.\', \'Heart, Vascular and Thoracic Institute, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.\', \'Cleveland Clinic, Cleveland, Ohio.\', \'Lerner Research Institute, Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, Ohio.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamacardio.2020.1855
?:hasPublicationType
?:journal
  • JAMA cardiology
is ?:pmid of
?:pmid
?:pmid
  • 32936273
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.551
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all